INTRODUCTION: Mitochondria are cellular organelles that perform numerous bioenergetic, biosynthetic, and regulatory functions and play a central role in iron metabolism. Extracellular iron is taken up by cells and transported to the mitochondria, where it is utilized for synthesis of cofactors essential to the function of enzymes involved in oxidation-reduction reactions, DNA synthesis and repair,…
Expert Review of Hematology Template
Write in a clean editor, then format for Expert Review of Hematology in one click — DocuGuru applies the official Taylor & Francis template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Expert Review of Hematology format
Expert Review of Hematology is a peer-reviewed journal published by Taylor & Francis, covering Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Numbered (Vancouver/NLM) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Expert Review of Hematology. 2023;12(3):45–58.
Formats any DOI in Expert Review of Hematology style. No sign-up. |
| Publishes research in | Lymphoma Diagnosis and Treatment Acute Myeloid Leukemia Research Chronic Lymphocytic Leukemia Research Platelet Disorders and Treatments Hemoglobinopathies and Related Disorders |
| ISSN | 1747-4086 |
| Citation impact (2-yr) | 2.01 |
| h-index | 69 |
| i10-index | 799 |
| Total citations | 29,247 |
| Top institutions publishing here | The University of Texas MD Anderson Cancer Center |
| Journal website | informahealthcare.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Expert Review of Hematology per year
Citation impact of Expert Review of Hematology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Expert Review of Hematology
Dyskeratosis congenita (DC) is a cancer-prone inherited bone marrow failure syndrome caused by aberrant telomere biology. The mucocutaneous triad of nail dysplasia, abnormal skin pigmentation and oral leukoplakia is diagnostic, but is not always present; DC can also be diagnosed by the presence of very short leukocyte telomeres. Patients with DC are at high risk…
Since allogeneic stem cell transplantation (SCT) represents an intensive curative treatment for high-risk malignancies, its failure to prevent relapse leaves few options for successful salvage treatment. While many patients have a high early mortality from relapse, some respond and have sustained remissions, and a minority has a second chance of cure with appropriate therapy. The…
The β-thalassemias, including the hemoglobin E disorders, are not only common in the Mediterranean region, South-East Asia, the Indian subcontinent and the Middle East but have now become a global problem, spreading to much of Europe, the Americas and Australia owing to migration of people from these regions. Approximately 1.5% of the global population are…
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative procedure for a variety of hematologic malignancies. The field has evolved substantially over the past decade, with advances in patient and donor selection, stem cell sources, supportive care, prevention of complications and reduced-toxicity preparative regimens. As a result, the indications for HCT and the pool of…